Drug intelligence / Profile preview

SIAH2 siRNA

Development stage
Preclinical
Lead developer
Eastern Virginia Medical School
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

SIAH2 siRNA is a small interfering RNA designed to silence the expression of the Seven in Absentia homolog 2 (SIAH2) gene. SIAH2 is a RING finger E3 ubiquitin ligase that serves as a critical signaling node downstream of the EGFR/HER2/K-RAS pathway. By inhibiting SIAH2, this therapy induces oxidative stress, mitochondrial dysfunction, and apoptosis in cancer cells, particularly those addicted to oncogenic K-RAS signaling. Preclinical studies have demonstrated that SIAH2 knockdown leads to increased reactive oxygen species (ROS) production and decreased phosphorylation of ERK1/2 and AKT, effectively combating invasive and metastatic cancer lines such as non-small cell lung adenocarcinoma and breast cancer.

Other names
anti-SIAH2 therapyanti-SIAH-2 therapyanti-SIAH 2 therapySIAH2 knockdownSIAH-2 knockdownSIAH 2 knockdown
02

Targets

E3 ligase (E3 ubiquitin ligases)

Beyond the preview

Go deeper on SIAH2 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIAH2 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call